Business
AstraZeneca moves to start making a profit from its vaccine – Sydney Morning Herald
After looking on as Pfizer and Moderna have made billions of dollars in sales, AstraZeneca is shifting to a for-profit model.
The vaccine isnt yet authorised in the US, after the company missed the window for an emergency authorisation due to the complicated nature of its trial results. Astra is planning to submit the shot for approval to regulators in the first half of next year,…
Continue Reading
-
General24 hours agoHuman remains located, police make arrest in search for Sunbury man Joshua Bishop
-
General22 hours agoNetanyahu denounces report IDF soldiers had orders to shoot Gaza aid-seekers
-
General14 hours ago“Accumulation of defects”. A-G report scathing on Navy shipbuilding
-
General14 hours agoG7 agrees to avoid higher taxes for US, UK companies